Recombinant SARS-CoV-2 Nucleocapsid His Protein, CF 10474-CV-050 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemRecombinant SARS-CoV-2 Nucleocapsid His Protein, CF
CompanyR&D Systems, a Bio-Techne Brand
Price $454.00Supplier Page View Company Product Page
Catalog Number10474-CV-050
Size50 ug (also 1 mg)
ApplicationsBioactivity not tested
Conjugate/TagUnconjugated
FormatLyophilized from a 0.2 µm filtered solution in PBS
Purity>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining
Molecular WeightObserved: 44-53 kDa, under reducing conditions
Theoretical: 46 kDa
SpeciesSARS-CoV-2
Molecule NameNucleocapsid
Source/Expression SystemSf 21 (baculovirus)-derived Recombinant SARS-CoV-2 Nucleocapsid His Protein, CF
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

(1) Investigation of SARS-CoV-2 individual proteins reveals the in vitro and in vivo immunogenicity of membrane proteinScientific reportsDecember 18, 2023Haystead T, Lee E, Cho K, Gullickson G, Hughes P, Krafsur G, Freeze R, Scarneo S.,R&D Systems,10500-CV-100 SARS-CoV-2 Spike Protein Full Length,R&D Systems,10549-CV-100 SARS-CoV-2 Nucleocapsid,R&D Systems,10474-CV-050 Reagents.

(2) Class switch towards spike protein-specific IgG4 antibodies after SARS-CoV-2 mRNA vaccination depends on prior infection historyScientific reportsAugust 13, 2023Kiszel P, Sík P, Miklós J, Kajdácsi E, Sinkovits G, Cervenak L, Prohászka Z.biotecne",10594-CV-100 "Recombinant SARS-CoV-2 nucleocapsid His protein, CF","R&D systems, biotecne",10474-CV-050 Software,Software,Software GraphPad Prism 9 software,GraphPadSoftwares Inc,https://www.graphpad.com/scientific-software/prism/ Key

(4) Evidence, detailed characterization and clinical context of complement activation in acute multisystem inflammatory syndrome in childrenScientific reportsNovember 17, 2022Sinkovits G, Schnur J, Hurler L, Kiszel P, Prohászka ZZ, Sík P, Kajdácsi E, Cervenak L, Maráczi V, Dávid M, et al.

(5) Calcium dobesilate reduces SARS-CoV-2 entry into endothelial cells by inhibiting virus binding to heparan sulfateScientific reportsOctober 7, 2022Kiyan Y, Schultalbers A, Chernobrivaia E, Tkachuk S, Rong S, Shushakova N, Haller H.

Nucleocapsid His-tag Protein